Breakthrough therapies at Stanford are saving lives. Can we afford them?Cell and gene therapies offer promising medical solutions but come with a hefty price tag, raising concerns about availability and affordability.
Swiss startup creates modular device for on-demand cell therapy manufacturingAutomated cell therapy manufacturing with less stress and contamination through modular device.
Breakthrough therapies at Stanford are saving lives. Can we afford them?Cell and gene therapies offer promising medical solutions but come with a hefty price tag, raising concerns about availability and affordability.
Swiss startup creates modular device for on-demand cell therapy manufacturingAutomated cell therapy manufacturing with less stress and contamination through modular device.
A promising glioblastoma clinical trial: Cancer researchers say tumors dramatically shrunkNovel cell therapy shrinks glioblastoma tumors dramaticallyCAR-T cell therapy shows promising results in Phase 1 trial
'Dramatic' inroads against aggressive brain cancer- Harvard GazetteCutting-edge cell therapy shows promising results in glioblastoma patientsCombination therapy approach offers potential for more effective treatment in solid tumors like glioblastoma
A promising glioblastoma clinical trial: Cancer researchers say tumors dramatically shrunkNovel cell therapy shrinks glioblastoma tumors dramaticallyCAR-T cell therapy shows promising results in Phase 1 trial
'Dramatic' inroads against aggressive brain cancer- Harvard GazetteCutting-edge cell therapy shows promising results in glioblastoma patientsCombination therapy approach offers potential for more effective treatment in solid tumors like glioblastoma
Daily briefing: Indigenous Australians started fire farming 11,000 years agoIndigenous Australians used fire-stick farming techniques to control wildfires thousands of years agoFirst cell therapy for solid tumors approved by FDA, paving the way for cheaper cancer treatments
CAR T therapy for multiple sclerosis enters US trials for first timeCAR T cells are being used in US trials for multiple sclerosis and other autoimmune disorders.CAR T cells show potential to provide more effective treatment for autoimmune diseases like multiple sclerosis.
FDA approves first cell therapy to treat aggressive forms of melanomaAmtagvi is the first cell therapy for solid tumors approved by the FDAIt is designed to treat aggressive forms of melanoma that cannot be removed with surgery or have spread to other parts of the body